Healthcare Transactions and Regulatory
The combination of our senior transactional counsel and our regulatory expertise makes us valued counsel in closing healthcare industry mergers, acquisitions, joint ventures, affiliations and other collaborations. Our practice is national in scope and involves all substantive aspects of healthcare transactions, including multistate regulatory approvals, legal risk assessments, tax structuring, antitrust analysis, and public company and going-private issues.
October 4, 2021
Study Shows Hospital M&A Deals Linked to Improved Quality of Care
April 2, 2021
Florida Passes Law Limiting COVID-19 Lawsuits
February 3, 2021
Implementation of Final Rule Excluding PBM Rebates from Discount Safe Harbor Delayed Until 2023
November 24, 2021
M&A partner Parveet Singh Gandoak joins the firm’s Corporate, Finance and Investments practice group in Singapore
November 23, 2021
King & Spalding Recruits Parveet Singh Gandoak as M&A Partner in Singapore
January 26, 2021
Healthcare partner Rick Zall joins the firm’s healthcare transactional and regulatory practice group in New York
November 16, 2021
DL Software group acquires Sephira
August 11, 2021
Sharecare Acquires Digital On-Demand Platform CareLinx
Norm Armstrong to Speak at ABA’s Antitrust in Healthcare Conference
View all events